BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 27739337)

  • 1. Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
    Svensson T; Lundström KL; Höglund M; Cherif H
    Ups J Med Sci; 2017 Mar; 122(1):56-60. PubMed ID: 27739337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
    Hsu LY; Ding Y; Phua J; Koh LP; Chan DS; Khoo KL; Tambyah PA
    BMC Infect Dis; 2010 Mar; 10():44. PubMed ID: 20199673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates.
    Zak P; Vejrazkova E; Zavrelova A; Pliskova L; Ryskova L; Hubacek P; Stepanova V; Kostal M; Koblizek V; Paterova P; Radocha J
    Folia Microbiol (Praha); 2020 Feb; 65(1):109-120. PubMed ID: 31073843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does molecular analysis increase the efficacy of bronchoalveolar lavage in the diagnosis and management of respiratory infections in hemato-oncological patients?
    Oren I; Hardak E; Zuckerman T; Geffen Y; Hoffman R; Yigla M; Avivi I
    Int J Infect Dis; 2016 Sep; 50():48-53. PubMed ID: 27484225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL.
    Boersma WG; Erjavec Z; van der Werf TS; de Vries-Hosper HG; Gouw AS; Manson WL
    Respir Med; 2007 Feb; 101(2):317-25. PubMed ID: 16774815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchoalveolar lavage as a diagnostic tool in patients with hematological malignancies and pneumonia.
    Cordani S; Manna A; Vignali M; Tascini C
    Infez Med; 2008 Dec; 16(4):209-13. PubMed ID: 19155686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of bronchoscopy in patients with hematologic malignancy and pulmonary infiltrates.
    Kim SW; Rhee CK; Kang HS; Lee HY; Kang JY; Kim SJ; Kim SC; Lee SY; Kim YK; Lee JW
    Ann Hematol; 2015 Jan; 94(1):153-9. PubMed ID: 25062720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of bronchoalveolar lavage in the management of immunocompromised patients presenting with lung infiltrates.
    Choo R; Naser NSH; Nadkarni NV; Anantham D
    BMC Pulm Med; 2019 Feb; 19(1):51. PubMed ID: 30808314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
    Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
    Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia.
    Dellière S; Amar Y; Hamane S; Aissaoui N; Denis B; Bergeron A; Tazi A; Alanio A
    Med Mycol; 2023 Dec; 61(12):. PubMed ID: 37996394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes.
    Fernández-Cruz A; Magira E; Heo ST; Evans S; Tarrand J; Kontoyiannis DP
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30021823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
    Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
    Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
    Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
    Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
    Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactomannan antigen detection using bronchial wash and bronchoalveolar lavage in patients with hematologic malignancies.
    Taremi M; Kleinberg ME; Wang EW; Gilliam BL; Ryscavage PA
    Ann Clin Microbiol Antimicrob; 2015 Nov; 14():50. PubMed ID: 26576545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Analysis of the Clinical Benefit of 37 Bronchoalveolar Lavage Procedures in Patients with Hematologic Disease and Pulmonary Complications.
    Katsumata Y; Terada J; Abe M; Suzuki K; Ishiwata T; Ikari J; Takeda Y; Sakaida E; Tsushima K; Tatsumi K
    Intern Med; 2019 Apr; 58(8):1073-1080. PubMed ID: 30568132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
    Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.
    Brownback KR; Pitts LR; Simpson SQ
    Mycoses; 2013 Sep; 56(5):552-8. PubMed ID: 23496321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.